Stephens lowered the firm’s price target on Bunge (BG) to $85 from $90 and keeps an Overweight rating on the shares after the company reported Q1 results. Near-term results are expected to remain challenged, but with the potential for a significant increase in the 2026 BBD RVO, board crush margins are seen being “healthy” in the back half of FY25, the analyst tells investors.
Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BG: